Role of interventional therapy in hepatic artery stenosis and non-anastomosis bile duct stricture after orthotopic liver transplantation

Table 1 General data pertaining to patients with HAS and non-stoma bile duct stricture

Case	Sex	Age	Primary disease	Hepatic artery			Bile duct
				Anastomosis Manifestation Time afterOLT (mo)			Anastomosis Manifestation Time afterOLT (mo)
1	M	41	Hepatic cirrhosis	End-to-end	Stoma stricture	6	End-to-end	Diffuse stricture	7
2	M	51	HCC	End-to-end	Stoma stricture	3	End-to-end	Diffuse stricture	4
3	M	42	Hemangiomas	End-to-end	Stoma stricture	4 d	End-to-end	Diffuse stricture	10
4	M	32	Hepatic cirrhosis	End-to-end	Stoma stricture	2	End-to-end	Diffuse stricture	21
5	M	65	HCC	End-to-end	HA occlusion	15	End-to-end	Diffuse stricture	17
6	M	37	Hepatic cirrhosis	End-to-end	Stoma stricture	12	End-to-end	Diffuse stricture	15
7	M	40	Re-hepatitis	Bypass	Stoma stricture	3	R-Y	Diffuse stricture	4
8	F	59	Re-hepatitis	Bypass	Stoma stricture	1	R-Y	Diffuse stricture	3
9	M	39	Hepatic cirrhosis	End-to-end	Stoma stricture	9	End-to-end	Diffuse stricture	11

HCC: Hepatocellular carcinoma; Re-hepatitis: Recurrent hepatitis; R-Y: Roux-en-Y anastomosis.